Investors / United States / General Inception
General Inception
Investor · Palo Alto, CA, United States · North America
General Inception is a deep tech venture studio that co-founds companies with scientific and technical founders. It provides executive talent, R&D and manufacturing services, back-office infrastructure, customer access, and initial co-founding capital to build companies from inception.
Invests inHealthcare & Biotech
In its own wordsdeep techventure studiocompany creationscienceproduct development
Your fit with General Inception
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGeneral Inception lists 23 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (84%), AI & Machine Learning (8%) and Industrial & Manufacturing (4%). 44% of its companies are based in United States. It invests most often alongside Paladin Capital Group, Genoa Ventures and +ND Capital.
Counts come from funding rounds that name General Inception, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not General Inception's whole history. Rounds on record name 2 companies; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 84% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Paladin Capital Group | 5 |
| Genoa Ventures | 2 |
| +ND Capital | 1 |
| Agoranov | 1 |
| Avant Bio | 1 |
| Capital Factory | 1 |
| Clave | 1 |
| Elderberry Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers23100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 84% | 15% |
| AI & Machine Learning | 8% | 18% |
| Industrial & Manufacturing | 4% | 7% |
| Climate & Energy | 4% | 1% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Paladin Capital Group
Compare General Inception head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with General Inception| Date | Company | Stage |
|---|---|---|
| 17 Mar 2026 | Seed | |
| 18 Nov 2025 | Seed |
Round details for General Inception
Amounts, full round histories and every co-investor in General Inception's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
23 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abbelight develops and provides microscopy and nanoscopy technology and solutions for various biological applications | Healthcare & Biotech | Portfolio page | ||
| AlidaBio develops breakthrough technologies for highly sensitive analysis of DNA methylation and RNA modifications from biological samples. | Healthcare & Biotech | Portfolio page | ||
| Axoiya develops and sells products for phosphotyrosine capture and proteomics research. | Healthcare & Biotech | Portfolio page | ||
| Basilard Biotech is a company that engineers cell-based therapies in Cell and Gene Therapy (CGT) using a novel gene delivery technology platform called Celletto | Healthcare & Biotech | Portfolio page | ||
| Biocellis is transforming diagnostic testing with breakthrough immunoassay technology | Healthcare & Biotech | Portfolio page | ||
| CryoVeritas develops temperature indicators to monitor the integrity of vaccines and biospecimens against heat exposure. | Healthcare & Biotech | Portfolio page | ||
| Detective Biosciences is developing a blood-based cancer detection test by analyzing patients' DNA epigenetic profiles. | Healthcare & Biotech | Portfolio page | ||
| Ennovate Pharma is an early-stage biotech company specializing in developing novel personalized therapies for autoimmune and inflammatory diseases | Healthcare & Biotech | Portfolio page | ||
| Exodigm is developing extracellular organic sensors to monitor intracellular genomic and transcriptomic content in living cells. | Healthcare & Biotech | Portfolio page | ||
| Exponential Molecular develops and sells technology for preserving and analyzing molecular samples | Healthcare & Biotech | Portfolio page | ||
| Hermes Biosciences has developed an automated benchtop system that isolates EVs and cfDNA together from a single plasma draw | Healthcare & Biotech | Nov 2025Seed | Funding round | |
| Hermes Biosciences has developed an automated benchtop system that isolates EVs and cfDNA together from a single plasma draw. | Healthcare & Biotech | Portfolio page | ||
| Inapill is developing small molecule therapeutics for the treatment of inflammatory, autoimmune, and age-related diseases. | Healthcare & Biotech | Portfolio page | ||
| Origin Peptides develops technology for peptide synthesis, making production faster, environmentally friendly and less expensive | Healthcare & Biotech | Portfolio page | ||
| Partillion generates cell-cell interaction data for biological research and applications | Healthcare & Biotech | Portfolio page | ||
| Pharmacelera develops proprietary Computer-Aided Drug Design software based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing | Healthcare & Biotech | Portfolio page | ||
| Planet Smart designs polyaminoacid polymers that match or beat the performance of current specialty polymers and then break down when their job is done | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Roxbiosens is developing sequencing-independent tools to analyze complex ecosystems such as the gut microbiome by measuring their bioenergetic status | Healthcare & Biotech | Portfolio page | ||
| The company develops innovative solutions for comprehensive analysis of chromatin modifications and gene expression at the level of the single cell. | Healthcare & Biotech | Portfolio page | ||
| Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform for treatment of chronic inflammatory disorders | Healthcare & Biotech | Mar 2026Seed | Funding round |
About this data
site last read 5 Nov 2026- Site
- generalinception.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 18 Nov 2025
- Companies checked
- 23
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get General Inception's profile as data
Pull General Inception's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/generalinception.com
# also
GET /v1/firms/generalinception.com/portfolio
GET /v1/firms/generalinception.com/coinvestors
GET /v1/firms/generalinception.com/news